Publications by authors named "Neja Samec"

Claim this Profile
A
and are overexpressed in glioblastoma and associated with immunosuppressive microenvironment.
Alja Zottel, Neja Šamec, Ivana Jovčevska

Biomol Biomed· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From Biomarker Discovery to Clinical Applications of Metabolomics in Glioblastoma.
Neja Šamec, Gloria Krapež, Cene Skubic, Ivana Jovčevska, Alja Videtič Paska

Metabolites· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Slovenian translational platform GlioBank for brain tumor research: Identification of molecular signatures of glioblastoma progression.
Metka Novak, Bernarda Majc, Marta Malavolta, Andrej Porčnik, Jernej Mlakar

Neurooncol Adv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro Functional Validation of an Anti-FREM2 Nanobody for Glioblastoma Cell Targeting.
Gloria Krapež, Neja Šamec, Alja Zottel, Mojca Katrašnik, Ana Kump

Antibodies (Basel)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-animal glioblastoma models for personalized treatment.
Alja Zottel, Ivana Jovčevska, Neja Šamec

Heliyon· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sonication is a suitable method for loading nanobody into glioblastoma small extracellular vesicles.
Sara Colja, Ivana Jovčevska, Neja Šamec, Rok Romih, Alja Zottel

Heliyon· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Vimentin Nanobody Decreases Glioblastoma Cell Invasion In Vitro and In Vivo.
Alja Zottel, Metka Novak, Neja Šamec, Bernarda Majc, Sara Colja

Cancers (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Technologies for RNA-Directed Liquid Diagnostics.
Maria Victoria Martinez-Dominguez, Alja Zottel, Neja Šamec, Ivana Jovčevska, Can Dincer

Cancers (Basel)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OligoPrime: An Information System for Oligonucleotide Management.
Šimen Ravnik, Ines Žabkar, Uršula Prosenc Zmrzljak, Ivana Jovčevska, Neja Šamec

Biomed Eng Comput Biol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Algorithmically Deduced Molecular Pathway Is a Potent Grade and Survival Biomarker of Human Gliomas.
Marianna Zolotovskaia, Victor Tkachev, Maxim Sorokin, Andrew Garazha, Ella Kim

Cancers (Basel)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRIM28 Selective Nanobody Reduces Glioblastoma Stem Cell Invasion.
Andrej Porčnik, Metka Novak, Barbara Breznik, Bernarda Majc, Barbara Hrastar

Molecules· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large-Scale Transcriptomics-Driven Approach Revealed Overexpression of as a Poor Survival Prognosis Biomarker in Glioblastoma.
Maxim Sorokin, Mikhail Raevskiy, Alja Zottel, Neja Šamec, Marija Skoblar Vidmar

Cancers (Basel)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytoskeletal proteins as glioblastoma biomarkers and targets for therapy: A systematic review.
Alja Zottel, Ivana Jovčevska, Neja Šamec, Radovan Komel

Crit Rev Oncol Hematol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles.
Alja Zottel, Neja Šamec, Ana Kump, Lucija Raspor Raspor Dall'Olio, Pia Pužar Dominkuš

Int J Mol Sci· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coding of Glioblastoma Progression and Therapy Resistance through Long Noncoding RNAs.
Alja Zottel, Neja Šamec, Alja Videtič Paska, Ivana Jovčevska

Cancers (Basel)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration.
Alja Zottel, Ivana Jovčevska, Neja Šamec, Jernej Mlakar, Jernej Šribar

Ther Adv Med Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanomedicine and Immunotherapy: A Step Further towards Precision Medicine for Glioblastoma.
Neja Šamec, Alja Zottel, Alja Videtič Paska, Ivana Jovčevska

Molecules· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Gene and Protein Expression Are Associated with Favorable Prognosis of -WT Glioblastomas.
Ivana Jovčevska, Alja Zottel, Neja Šamec, Jernej Mlakar, Maxim Sorokin

Cancers (Basel)· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-Analysis and Experimental Validation Identified FREM2 and SPRY1 as New Glioblastoma Marker Candidates.
Marko Vidak, Ivana Jovcevska, Neja Samec, Alja Zottel, Mirjana Liovic

Int J Mol Sci· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glioblastoma-specific anti-TUFM nanobody for immunoimaging and cancer stem cell targeting.
Neja Samec, Ivana Jovcevska, Jure Stojan, Alja Zottel, Mirjana Liovic

Oncotarget· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis